A novel splice-site mutation c.42-2A>T (IVS1-2A>T) of SERPINC1 in a Korean family with inherited antithrombin deficiency.

Inherited antithrombin (AT) deficiency (OMIM 107300) is an autosomal dominant disorder and causes a 20-fold increase in the risk of venous thromboembolism. Herein, we describe a case of a novel splice-site mutation in the SERPINC1 gene in a Korean patient with inherited AT deficiency. The patient was a 35-year-old woman who presented with deep vein thrombosis (DVT) and pulmonary embolism and was without a recent history of any precipitating factors. The obtaining of her family history revealed that her mother had an ischemic stroke and a pulmonary embolism and her two sisters both had an episode of DVT during pregnancy. DNA sequencing of SERPINC1 revealed the novel variant IVS1-2A>T (c.42-2A>T), a substitution in intron 1, in the proband and her daughter. The mutation IVS1-2A>T eliminates the acceptor splice-site of intron 1. The present case is the first novel splice-site mutation of SERPINC1 in a Korean family with inherited AT deficiency.

[1]  Hee-Jin Kim,et al.  A heparin binding site Arg79Cys missense mutation in the SERPINC1 gene in a Korean patient with hereditary antithrombin deficiency. , 2011, Annals of clinical and laboratory science.

[2]  F R Rosendaal,et al.  Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT) , 2005, Journal of thrombosis and haemostasis : JTH.

[3]  Vittorio Pengo,et al.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT) , 1996, The Lancet.

[4]  S. Thein,et al.  THE MOLECULAR GENETICS OF ANTITHROMBIN DEFICIENCY , 1994, Blood reviews.

[5]  R. Carrell,et al.  Prevalence of antithrombin deficiency in the healthy population , 1994, British journal of haematology.

[6]  P. Wells,et al.  Prevalence of antithrombin deficiency in healthy blood donors: A cross‐sectional study , 1994, American journal of hematology.

[7]  D. Perry Antithrombin and its inherited deficiencies. , 1994, Blood reviews.

[8]  P. Kyrle,et al.  Hereditary deficiency of antithrombin III, protein C and protein S: prevalence in patients with a history of venous thrombosis and criteria for rational patient screening , 1992, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[9]  R. Carrell,et al.  The incidence of dysfunctional antithrombin variants: four cases in 210 patients with thromboembolic disease , 1991, British journal of haematology.

[10]  J. Fiessinger,et al.  Antithrombin III synthesis in rat liver parenchymal cells. , 1983, Thrombosis research.

[11]  O. Egeberg Inherited Antithrombin Deficiency Causing Thrombophilia , 1965, Thrombosis and Haemostasis.

[12]  E. Seifried,et al.  Blood Coagulation , Fibrinolysis and Cellular Haemostasis Molecular basis of antithrombin deficiency , 2012 .

[13]  R. Tait,et al.  Hereditary and acquired antithrombin deficiency: epidemiology, pathogenesis and treatment options. , 2007, Drugs.

[14]  J. Vandenbroucke,et al.  Bleeding complications in oral anticoagulant therapy. An analysis of risk factors. , 1993, Archives of internal medicine.